The Procter & Gamble Company Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
The Procter & Gamble Company (PG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $151.43 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-08-04
- The Procter & Gamble Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2026 was $151.43, a 0.38% increase from fiscal 2025.
- The Procter & Gamble Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2025 was $150.86, a 12.01% increase from fiscal 2024.
- The Procter & Gamble Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2024 was $134.69, a 4.90% increase from fiscal 2023.
- The Procter & Gamble Company share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $128.40, a 10.33% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2026-06-30 | $151.43 10-K · filed 2026-08-04 |
| 2025-06-30 | $150.86 10-K · filed 2025-08-04 |
| 2024-06-30 | $134.69 10-K · filed 2024-08-05 |
| 2023-06-30 | $128.40 10-K · filed 2023-08-04 |
| 2022-06-30 | $116.38 10-K · filed 2022-08-05 |
| 2021-06-30 | $106.72 10-K · filed 2021-08-06 |
| 2020-06-30 | $83.23 10-K/A · filed 2020-08-07 |
| 2019-06-30 | $81.58 10-K · filed 2019-08-06 |
| 2018-06-30 | $82.92 8-K · filed 2018-10-22 |
| 2017-06-30 | $69.76 10-K · filed 2017-08-07 |
| 2016-06-30 | $73.70 10-K · filed 2016-08-09 |
| 2015-06-30 | $70.46 8-K · filed 2015-10-26 |
| 2014-06-30 | $65.09 10-K · filed 2014-08-08 |
| 2013-06-30 | $60.97 8-K · filed 2013-10-28 |
| 2012-06-30 | $59.12 10-K · filed 2012-08-08 |
| 2011-06-30 | $57.81 8-K · filed 2012-02-10 |
| 2010-06-30 | $55.23 10-K · filed 2010-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |